AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06492057 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Electromyography (EMG)
Description: As a standard method, surface EMG collects data from nerve impulse-triggered active muscle contractions, pre/postflight only
Study NCT06492057 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Description: MRI is a clinically standard (non-radiation) imaging method to study structural changes of the human body (organs, muscle, bones, tendons) at the macroscopic level, pre/postflight only
Study NCT06492057 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Dynamometry
Description: Dynamometry is a standard functional and diagnostic method to test muscle strength in sports and rehabilitation. pre/postflight only
Study NCT05928689 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol Hydrochloride tablet
Description: Single dose of 40 mg propranolol tablet
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exemestane
Description: 25mg, qd orally
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exemestane
Description: 25mg, qd orally
Study NCT06257069 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tremor Retrainer Smartphone Application
Description: The Tremor Retrainer smartphone application uses the smartphone's built-in accelerometer to calculate a patient's tremor frequency when the smartphone is strapped to the patient's wrist. The application will provide auditory cues to the patient with a treatment frequency at 2/3 the patient's baseline tremor frequency for half a session, then 1/3 the patient's baseline tremor frequency for the second half of the session. Meanwhile, oscillatory movements will be continuously analyzed with frequency calculated and displayed relative to goal frequency, so that the patient receives continuous feedback via a visual dial as to whether they are meeting treatment goals. Intervention will consist of a one-week Tremor Retrainment Protocol.
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamoxifen
Description: 10mg, bid orally
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Description: 10mg, bid orally
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Toremifene
Description: 60mg, qd orally
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toremifene
Description: 60mg, qd orally
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Abemaciclib
Description: 150mg/100mg/50mg, bid orally for 2 years
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: 150mg/100mg/50mg, bid orally for 2 years
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: LHRH agonist
Description: Leuprorelin acetate, goserelin acetate
Study NCT05891093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LHRH agonist
Description: Leuprorelin acetate, goserelin acetate
Study NCT04880395 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intervention Arm: dolutegravir/lamivudine
Description: 1 pill QD
Study NCT04880395 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Comparator ARM: TDF/XTC plus Dolutegravir (XTC stand for lamivudine OR emtricitabine)
Description: 1 pill of each QD
Study NCT06439875 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: effect of L-arginine and liposomial vitamin C on pulmonary rehabilitation
Description: Patients with a certified diagnosis of COPD and chronic respiratory failure will be randomized in a 1:1 ratio into the interventional arm or the placebo controller arm. All patients will undergo multidisciplinary intensive pulmonary rehabilitation for 28 days. The patients in the interventional group will receive a twice-daily oral supplementation with either a combination of 1.66 g l-arginine plus 500 mg liposomal vitamin C
Study NCT06439875 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Patients in this arm will undergo multidisciplinary intensive pulmonary rehabilitation without any dietary supplementation.
Study NCT05928689 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminder
Description: Reactivation of misophonia trigger memory
Study NCT05928689 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Reminder
Description: Reactivation of misophonia trigger memory
Study NCT05206032 — intervention group
Intervention type: OTHER
Intervention: Raman spectroscopy
Description: Blood (serum or plasma) will be collected, processed and analysed through Raman spectroscopy. Data acquired will be normalized and treated for the creation of the classification model.
Study NCT05928689 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counterconditioning
Description: Counterconditioning will consist of presentation of misophonia cues paired with monetary rewards.
Study NCT05928689 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo tablet
Study NCT06574932 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multi-Strategic Approach
Description: The experimental group will be engaged in multi-strategy approaches including screen time and sanity challenges, weekly screen-free days, screen time reduction goals, screen time tracking, structured daily routines, parental involvement, and monitoring, family media plans, alternative engagements, and promotion of offline social interactions.
Study NCT06092788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTP42:KVA4 Capsule
Description: Single doses of NTP42:KVA4 administered to healthy volunteers as a capsule
Study NCT06092788 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: NTP42:KVA4 Liquid
Description: Single doses of NTP42:KVA4 administered to healthy volunteers as a liquid
Study NCT05896865 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Whole breast / chest wall & regional lymph node irradiation
Description: Whole breast / chest wall and corresponding regional lymph node irradiation with dose of 42.4 Gy in 16 fractions
Study NCT05896865 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Internal mammary or supraclavicular lymph node boost
Description: Simultaneous boost to Internal mammary or supraclavicular lymph node area with dose of total 53.6 Gy or 56.0 Gy in 16 fractions, depending on the response after neoadjuvant chemotherapy
Study NCT05967572 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Research processes;
Description: 1. Before Inspection: information will be obtained and premature babies will be monitored by wearing a pulse oximeter device and their heart rate and oxygen saturation value will be recorded for control purposes. By making video recordings of each premature baby; PIPP pain score, PBIC comfort score, control oxygen saturation and peak heart rate values will be recorded 3 minutes before the ROP examination. Babies will be fed and changed at least half an hour before the examination.~2. Inspection Sequence: PIPP pain score, PBIC comfort score, control oxygen saturation and peak heart rate values will be recorded and evaluated from the video recording that continues with the start of the examination.~3. End of Inspection: Infants whose both eye examinations are completed and whose monitoring and video recording continue will be recorded and evaluated 3 minutes after the end of the examination, with PIPP pain score, PBIC comfort score, control oxygen saturation and heart rate values.
Study NCT04856007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin/metformin XR FDC 5/500 mg
Description: In cohort 1, subjects will be randomized to receive co-administration of a single oral dose of a 5mg dapagliflozin tablet and a 500mg metformin XR tablets (Treatment A) followed by 7 to 14 days washout and then receive single FDC tablet consisting of 5mg dapagliflozin and 500mg metformin XR (Treatment B) on Day 1 in one treatment sequence. Or subjects will be randomized to be administered the Treatment B followed by 7 to 14 days washout and then received Treatment A on Day1 in the other treatment sequence.
Study NCT04856007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin/metformin XR FDC 10/1000 mg
Description: In cohort 2, subjects will be randomized to receive co-administration of a single oral dose of a 10mg dapagliflozin tablet and two 500mg metformin XR tablets (Treatment C) followed by 7 to 14 days washout and then receive single FDC tablet consisting of 10mg dapagliflozin and 1000mg metformin XR (Treatment D) on Day 1 in one treatment sequence. Or subjects will be randomized to be administered the Treatment D followed by 7 to 14 days washout and then received Treatment C on Day1 in the other treatment sequence.
Study NCT04856007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 5 mg + Metformin 500 mg XR
Description: In cohort 1, subjects will be randomized to receive co-administration of a single oral dose of a 5mg dapagliflozin tablet and a 500mg metformin XR tablets (Treatment A) followed by 7 to 14 days washout and then receive single FDC tablet consisting of 5mg dapagliflozin and 500mg metformin XR (Treatment B) on Day 1 in one treatment sequence. Or subjects will be randomized to be administered the Treatment B followed by 7 to 14 days washout and then received Treatment A on Day1 in the other treatment sequence.
Study NCT04856007 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg + Metformin 1000 mg XR
Description: In cohort 2, subjects will be randomized to receive co-administration of a single oral dose of a 10mg dapagliflozin tablet and two 500mg metformin XR tablets (Treatment C) followed by 7 to 14 days washout and then receive single FDC tablet consisting of 10mg dapagliflozin and 1000mg metformin XR (Treatment D) on Day 1 in one treatment sequence. Or subjects will be randomized to be administered the Treatment D followed by 7 to 14 days washout and then received Treatment C on Day1 in the other treatment sequence.
Study NCT06575504 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ultrasonographical examination
Description: Study size and Doppler / blood flow / of the suprarenal gland
Study NCT06574672 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Embedded Hospice and Palliative Care Practitioner
Description: The hospice and palliative care practitioner will be embedded in one medical intensive care unit for the first half of the study timeframe, after which the practitioner will expand to both medical intensive care units. While active in a medical intensive care unit, the practitioner will proactively trigger palliative care consultations based on clinical criteria and estimated mortality risk, in addition to providing immediate availability for standard-of-care hospice or palliative care consultations.
Study NCT06574672 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Embedded Hospice and Palliative Care Practitioner (Group Effect)
Description: While the hospice and palliative care practitioner is active in one medical intensive care unit with respect to triggering consultations, the other medical intensive care unit can still utilize the practitioner's services for standard-of-care hospice or palliative care consultations.
Study NCT06574672 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: None (Historical)
Description: This control arm includes historical patients admitted to the medical intensive care units prior to the study's enrollment timeframe.
Study NCT06574776 — intervention group
Intervention type: OTHER
Intervention: Observation and collecting data
Description: In that single cohort we will collect data on MDRO infection and colonization prevalence, clinical characteristics, infections, causative organisms and mortality.
Study NCT06144164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate Lymphatic Reconstruction
Description: Immediate Lymphatic Reconstruction will happen at the time of Axillary Lymph Node Dissection
Study NCT06144164 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Volumetric arm measurements
Description: Volumetric arm measurements will occur at each in-person postoperative visit time points.
Study NCT06144164 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lymphatic massage
Description: Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed
Study NCT04753840 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs
Description: One of ACEI / ARB, beta blocker, calcium channel blocker, diuretic
Study NCT04753840 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: remote ischemic preconditioning（RIPC）
Description: 40 minutes per day, 10 minutes as a cycle (cuff inflated to 200 mmHg and maintained for 5 minutes, then deflated for 5 minutes to start the next cycle)， a total of 4 cycles.
Study NCT06144164 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Range of motion exercises
Description: Participants will begin self-directed lymphatic massage 24 to 48 h after surgery and will continue to do lymphatic massage 3 times a week for 3 months after surgery or until 3 months after any adjuvant treatments (chemotherapy, radiation, etc.) are completed
Study NCT06144164 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Compression garment use
Description: Participants will use compression garments 24 to 48 h after surgery and will continue daily use for at least 8 h a day for 3 months or until 3 months after any adjuvant treatments are completed
Study NCT04753840 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: lifestyle intervention
Description: Such as changing dietary habits, smoking cessation and alcohol restriction, exercise and so on.
Study NCT04753840 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: lifestyle intervention
Description: Such as changing dietary habits, smoking cessation and alcohol restriction, exercise and so on.
Study NCT05063279 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Description: Progressive resistance training, performed with a target number of repetitions of 10 per set. Sets are performed to exhaustion, and external load will be adjusted to meet the target number of repetitions.
Study NCT05918926 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Individualised remote exercise intervention
Study NCT06038565 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RAM cannula ventilator CPAP
Description: RAM cannula ventilator CPAP
Study NCT06038565 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: RAM cannula ventilator CPAP
Description: RAM cannula ventilator CPAP
Study NCT06038565 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Occlusive interface bubble CPAP
Description: Occlusive interface bubble CPAP
Study NCT06038565 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Occlusive interface bubble CPAP
Description: Occlusive interface bubble CPAP
Study NCT05411458 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Aerobic and Relaxation Exercises
Description: 12-week treatment program; A - 6 weeks of aerobic exercise (AE) (outdoor walking program) 6 week program B - Jacobson Progressive Relaxation Exercises (JIGE) (done by patients at home). The 6-week B program (JIGE) was applied in addition to the aerobic exercise (AE) program.~Aerobic exercise (AE) program:The aerobic training program was applied as walking for 40 minutes in the open air. The Rating of Perceived Exertion (RPE) Borg Scale (6-20) was used to determine the walking pace, and they were asked to walk according to the light (11-12) level according to the Borg scale.~An exercise program is 30-45 minutes, and the applications are done every other day and 3 days a week.The treatment programs started with the evaluation of the cases by the physiotherapist and are followed up using the Telerehabilitation method. At the beginning of each week, the patients were called and checked, and their exercise treatments were completed at the end of 12 weeks.
Study NCT05411458 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic and Relaxation Exercises
Description: 12-week treatment program; A - 6 weeks of aerobic exercise (AE) (outdoor walking program) 6 week program B - Jacobson Progressive Relaxation Exercises (JIGE) (done by patients at home). The 6-week B program (JIGE) was applied in addition to the aerobic exercise (AE) program.~Aerobic exercise (AE) program:The aerobic training program was applied as walking for 40 minutes in the open air. The Rating of Perceived Exertion (RPE) Borg Scale (6-20) was used to determine the walking pace, and they were asked to walk according to the light (11-12) level according to the Borg scale.~An exercise program is 30-45 minutes, and the applications are done every other day and 3 days a week.The treatment programs started with the evaluation of the cases by the physiotherapist and are followed up using the Telerehabilitation method. At the beginning of each week, the patients were called and checked, and their exercise treatments were completed at the end of 12 weeks.
Study NCT05205265 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rivet Shunt
Description: The Rivet Shunt device will be implanted via a percutaneous, transcatheter approach
Study NCT05776264 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Music Condition
Description: During one of the sessions, participants will listen to music while walking on the treadmill for 10 minutes.
Study NCT05776264 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Podcast Condition
Description: During one of the sessions, participant will listen to a podcast for 10 minutes while walking on the treadmill.
Study NCT06163885 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stoma care education with flipped classroom
Description: Flipped classroom model will use for stoma care education.These training models will explore which of them will be most useful for participants in the acquisition of stoma care skills and knowledge. It will also monitor whether there is any change in the level of academic self-efficacy of nursing students who follow these educational models.
Study NCT06163885 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stoma care education with peer-supported education model
Description: Peer-supported education model will use for stoma care education.These training models will explore which of them will be most useful for participants in the acquisition of stoma care skills and knowledge. It will also monitor whether there is any change in the level of academic self-efficacy of nursing students who follow these educational models.
Study NCT05577988 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: single-antiplatelet with a low-potency antiplatelet (aspirin or clopidogrel) guided by genetic testing.
Description: * Individuals without genetic loss of function to metabolize clopidogrel: stop DAPT and switch to a single antiplatelet therapy by clopidogrel.~* Individuals with genetic loss of function to metabolize clopidogrel (\*2/\*3, 1/\*3, \*2/\*2, \*1/\*2): stop potent P2Y12 inhibitor and treat with a single antiplatelet therapy by aspirin.~* Individuals with fast metabolization of clopidogrel (\*1/\*17 or \*17/\*17): stop potent P2Y12 inhibitor and treat with a single antiplatelet therapy by aspirin.
Study NCT05697354 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation using interactive tablet
Description: the cognitive rehabilitation exercises will be administered using the Khymeia VRRS Home Tablet. Patients will be asked to actively carry out exercises focused on the following cognitive functions: language, attention, executive functions, verbal memory, visuo-spatial memory.
Study NCT05697354 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation using smartphone App Medico Amico
Description: the cognitive rehabilitation exercises will be administered through patients' smartphone using the Medico Amico App. Patients will be asked to observe and concentrate on exercises focused on the following cognitive functions: language, attention, executive functions, verbal memory, visuo-spatial memory.
Study NCT05748925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dapagliflozin
Description: The patients will be randomized into two groups Study group: will receive SGLT2i as add on drug or replace another drug according to the patient clinical situation, Dapagliflozin 10 mg will be used once daily with or without food.
Study NCT05748925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Description: Control group: will be maintained on their medication
Study NCT05046080 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Medical records reviewed
Study NCT05046080 — intervention group
Intervention type: OTHER
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT06163664 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Use of chatGPT for 1 week
Description: Use of chatGPT for 1 week
Study NCT06163664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Use of chatGPT for 1 week
Description: Use of chatGPT for 1 week
Study NCT05021133 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Tele-Navi LCS
Description: Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS using a video or telephone call
Study NCT05536973 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: ADVM-022
Description: A single IVT injection of 2E11 vg/eye ADVM-022 dose in combination with one (1) of four (4) corticosteroid treatment regimens